Tradestie Institutional Equity Comparison Engine

KTTA vs ENSC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KTTA Overall Edge

KTTA Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical while ENSC counters with relative strength in Valuation. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ENSC
KTTA N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner KTTA
Op Margin 0.0% vs -281.3% ยท YoY +1498.1% vs -15.1%
Momentum & Technical Winner KTTA
1Y +0.6% vs -80.3% ยท 52W Pos 11% vs 8%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap $17.7M
1M Return +7.52%
1Y Return +0.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 50.0 Mom 60.0
ENSC NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap $7.0M
1M Return -29.55%
1Y Return -80.33%
Forward P/E 0.8x
Unified AI Score
53.4 / 100 HOLD
Tech 50.0 Fund 62.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KTTA +0.59% ENSC -80.33% Spread: +80.92 pp (KTTA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period KTTA Revenue ENSC Revenue KTTA Op. Margin ENSC Op. Margin Margin Edge
FY2020 N/A $0M N/A -41.0% ENSC
FY2021 $0M $0M -29925.7% -562.7% ENSC
FY2022 $0M $0M -2587.3% -959.9% ENSC
FY2023 N/A $0M N/A -480.5% ENSC
FY2024 N/A $10M N/A -129.2% ENSC
FY2025 N/A $10M N/A -202.1% ENSC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KTTA (6) vs ENSC (4)
Institutional Metric KTTA ENSC Criterion Row Winner
Market Capitalization Scale $17.7M $7.0M Larger Scale KTTA
Trailing P/E Ratio Valuation N/M 0.8x Lower Multiple ENSC
Forward P/E Ratio Valuation N/M 0.8x Lower Multiple ENSC
Revenue Growth (YoY) Growth +1498.1% -15.1% Higher Growth KTTA
Operating Margin (TTM) Profitability 0.0% -281.3% Higher Margin KTTA
Net Profit Margin Profitability 0.0% -280.5% Higher Margin KTTA
Return on Equity (ROE) Capital Efficiency -88.8% -1295.1% Higher ROE KTTA
52-Week Range Position Momentum 11% ($0โ€“$2) 8% ($0โ€“$2) Stronger Trend KTTA
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 185% Vol 0.98ฮฒ ยท 79% Vol Lower Realized Risk ENSC
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 53.4 / 100 (HOLD) Higher Composite ENSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KTTA vs ENSC Buy Guide
KTTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ENSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KTTA nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.